Mitchell Lee Gaynor, MD Assistant Clinical Professor of Medicine, The New York Hospital, Cornell Medical Center; Medical Director and Director, Medical Oncology, Weill-Cornell Center for Complementary and Integrative Medicine, New York
Address: Mitchell Lee Gaynor, MD, The New York Hospital, Cornell Medical Center, 428 East 72nd Street, Suite 100, New York, NY 10021; e-mail: email@example.com
The author states that preparation of this article was supported by an unrestricted educational grant from Novogen, Inc.
ABSTRACTEpidemiologic and experimental data suggest that isoflavones have benefits for preventing and treating some prostate disease. Isoflavone supplements may therefore be an important tool for men concerned about prostate disease, such as those with benign prostatic hypertrophy undergoing watchful waiting or those concerned about the potential for prostate cancer. Conclusive proof of a relationship between isoflavones and the prevention and treatment of prostate disease can only come from prospective, randomized, controlled clinical trials.